Acute Hepatic Porphyria clinical trials at UCSF
2 in progress, 0 open to eligible people
Showing trials for
ENVISION: A Study to Evaluate the Efficacy and Safety of Givosiran (ALN-AS1) in Patients With Acute Hepatic Porphyrias (AHP)
Sorry, in progress, not accepting new patients
The purpose of this study is to evaluate the effect of subcutaneous givosiran (ALN-AS1), compared to placebo, on the rate of porphyria attacks in patients with Acute Hepatic Porphyrias (AHP).
San Francisco, California and other locations
EXPLORE: A Natural History Study of Acute Hepatic Porphyria (AHP)
Sorry, in progress, not accepting new patients
The purpose of this study is to characterize the natural history and clinical management of Acute Hepatic Porphyria (AHP) patients with recurring attacks.
San Francisco, California and other locations
Last updated: